Biosynex S.A.
ALBIO.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €19 | €89 | €117 | €224 |
| - Cash | €5 | €20 | €87 | €132 |
| + Debt | €62 | €66 | €52 | €35 |
| Enterprise Value | €76 | €135 | €82 | €128 |
| Revenue | €101 | €93 | €197 | €383 |
| % Growth | 8.8% | -52.7% | -48.6% | – |
| Gross Profit | -€20 | €49 | €65 | €183 |
| % Margin | -19.8% | 52.8% | 32.8% | 47.7% |
| EBITDA | -€18 | -€10 | €47 | €147 |
| % Margin | -17.6% | -11% | 23.8% | 38.3% |
| Net Income | -€43 | -€37 | €16 | €104 |
| % Margin | -42.8% | -39.7% | 8% | 27.2% |
| EPS Diluted | -3.32 | -2.85 | 1.26 | 8.27 |
| % Growth | -16.5% | -326.2% | -84.8% | – |
| Operating Cash Flow | -€10 | -€10 | €5 | €110 |
| Capital Expenditures | -€5 | -€40 | -€30 | -€19 |
| Free Cash Flow | -€15 | -€49 | -€25 | €91 |